Bioqube Ventures
Finance · Belgium · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Turnhoutseweg 30, Beerse, Flanders, 2340...Phone Number
+32 78626475Website
www.bioqubeventures.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Bioqube Ventures
Bioqube Ventures is a global life sciences investment firm that focuses on transforming scientific discoveries into innovative medicines. With offices in Belgium and the United States, the firm invests in companies developing first- or best-in-class therapeutics to meet significant unmet medical needs. They support a diverse portfolio of companies from inception through early clinical milestones, emphasizing bold scientific advancements. Their intended clients include startups and companies in the life sciences sector aiming to develop groundbreaking therapeutics.Explore more
Bioqube Ventures Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bioqube Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Bioqube Ventures launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Bioqube Ventures recently announced quarterly report
Click to see if Bioqube Ventures had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Bioqube Ventures is spiking on competitors!
Bioqube Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Bioqube Ventures has new funding data
Check if Bioqube Ventures has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Bioqube Ventures
Recommended Actions
Find VP level buyers at Bioqube Ventures
Find 2 more new buyers
Company Profile Activity
Activity Insights
Bioqube Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Bioqube Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Bioqube Ventures.
Bioqube Ventures Tech Stack
A closer look at the technologies used by Bioqube Ventures
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Bioqube Ventures News & Media
CatalYm Raises $150M in Series D Funding
CatalYm, a Munich, Germany-based company providing immune therapy solutions for solid tumors, raised $150M in Series D funding. The round was led by Canaan Partners and Bioqube Ventures, with participation from Forbion’s Growth Opportunities Fund (“Forbion Growth”), Omega Funds and Gilde Healthcare. Existing investors Jeito Capital, Brandon Capital Partners, Novartis Venture Fund and Vesalius Biocapital […] The post CatalYm Raises $150M in Series D Funding appeared first on FinSMEs.Anavo Therapeutics extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic
LEIDEN, The Netherlands & HEIDELBERG, Germany--(BUSINESS WIRE)--Anavo Therapeutics announced an extension of seed round financing, bringing the total seed round to EUR 28 million.ENHANC3D GENOMICS Awarded QuickFire Challenge Grant
Awarded grant funding from Johnson & Johnson Innovation and one year of JLABS residency Functional genomics technology focused on the uncharted non-coding regions across the whole human genome Identification of 3D genetic interactions that are disease-associated to revolutionise target...Metrion Biosciences and Bioqube Ventures Collaborate on Venture Creation Project to Identify Novel Ion Channel Inhibitors for Autoimmune Diseases
CAMBRIDGE, England & BRUSSELS--(BUSINESS WIRE)--Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, and Bioqube Ventures (“Bioqube”), a specialist European life sciences investment firm, announced today that they have entered into a collaboration, backed by Bioqube Factory Fund I, to incubate a drug discovery research project targeting autoimmune diseases. Under the terms of the collaboration, Bioqube and Metrion will advance a lead
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bioqube Ventures
Sign Up For FreeTo access detailed company insights
Bioqube Ventures is a global life sciences investment firm that focuses on transforming scientific discoveries into innovative medicines. With offices in Belgium and the United States, the firm invests in companies developing first- or best-in-class therapeutics to meet significant unmet medical needs. They support a diverse portfolio of companies... Read More
